Speaker Profile

MSc. Organic Chemistry, Associate Director Global Sourcing R&D+M, BoehringerIngelheim Pharmaceuticals, Inc.

Brian Raudenbush is the Associate Director of Global Sourcing R&D+M at BoehringerIngelheim Pharmaceuticals. Mr. Raudenbush holds a MS in Organic Chemistry from The Pennsylvania State University and from 2001-2005 worked as a medicinal chemist at Bayer and Novartis. In 2005, Mr. Raudenbush joined BoehringerIngelheim as a medicinal chemist and in 2010 was a key contributor to the design and synthesis of Idarucizumab (Praxbind), a novel monoclonal antibody designed for the reversal of the anticoagulant effects of Dabigatran (Pradaxa). During his time as a medicinal chemist, Mr. Raudenbush was a contributor on 8 patents and 2 scientific papers. In 2011, Mr. Raudenbush moved into the Global Sourcing Department. In his current role, Mr. Raudenbush is a category manager for global preclinical R&D services, the US human biospecimen acquisition manager and supports the evaluation of emerging technologies, such as microbiome research and new antibody generation platforms.


Challenges of Human Biospecimen Acquisition – Industry Perspective
When identifying and acquiring human biospecimens, Biopharma’s have a number of complex challenges to overcome to enable successful relationships with external sources. We discuss some of these challenges to provide a transparency into the industry to enable us to identify efficient, cost effective, compliant solutions.

Session Abstract – PMWC 2017 Silicon Valley

Session Synopsis: Pharma’s define the acquisition of human biospecimens as a very high-risk sourcing activity. This session looks at the risks and challenges, from an industry perspective, of acquiring samples and introduces a solution to remove the barriers, administrative burden, and reduce the cost for both Pharma’s and providers of samples.

Get Exclusive Access to the Top PMWC Talks

To receive the most comprehensive news and updates from the field of precision medicine, subscribe to the newsletter here.

Bonus for suscribing, you will get the access code for the top 3 talk videos from January's Precision Medicine World Conference.

You have successfully subscribed, you can access the talks here.